Examining the role of neurogranin in calcineurin activation in rodent skeletal muscle
Examining the role of neurogranin in calcineurin activation in rodent skeletal muscle
批准号:
RGPIN-2019-05833
负责人:
Fajardo, ValAndrew
金额:
$1.68万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
骨骼肌占我们身体质量的很大比例,不仅对运动和锻炼很重要,而且对包括能量代谢在内的其他日常功能也很重要。因此,保持肌肉质量对日常生活至关重要,幸运的是,我们的肌肉细胞有一种独特的能力,可以通过一种称为肌肉再生的过程来修复自己,以应对破坏性的压力。钙在骨骼肌生物学/生理学中是一个非常强大的信号,因为它不仅激活肌肉收缩,还激活一些蛋白质,有助于提高运动能力和肌肉的生长和修复能力。在我们的肌肉细胞,实际上是我们所有的细胞中,参与钙信号传递的一个关键蛋白质是钙调蛋白(CaM),它随着细胞内钙的增加而激活。一旦激活,CaM可以激活许多其他蛋白质(下游靶标),如钙调神经磷酸酶,它已被证明可以增强疲劳抗性和我们肌肉的生长和再生能力。令人惊讶的是,尽管CaM在钙信号和骨骼肌生物学/生理学中的重要性是众所周知的,但我们对CaM在肌肉细胞中是如何调控的知之甚少。相反,随着几种CaM结合蛋白的发现和鉴定,我们对CaM在大脑和神经细胞中的调控方式有了更多的了解,这些蛋白可以与CaM物理上相互作用,导致CaM下游靶标的激活增加或减少。一种特别的蛋白质是神经颗粒素(Ng),当它与CaM结合时,它会使其远离其他下游目标,如钙调神经磷酸酶,从而阻止其激活。最近,我们发现Ng不仅在脑细胞和神经细胞中表达,而且在我们的肌肉细胞中也可以发现,它可以与CaM结合。然而,我们仍然没有弄清楚Ng到底是如何调节骨骼肌中的CaM的,以及它是否会影响运动成绩、肌肉生长和修复。因此,这项研究计划的一个主要长期目标是确定Ng在我们的肌肉细胞中作为CaM调节器的作用。为此,我们将使用肌肉中没有Ng的转基因小鼠,我们将执行一些实验室技术,以弄清楚肌肉中CaM和钙调神经磷酸酶信号的变化,以及对肌肉收缩、生长和修复能力的影响。总体而言,这一基础研究将有助于更好地了解CaM在骨骼肌中的调控,并可能导致对骨骼肌生物学/生理学中其他CaM结合蛋白的探索。由于CaM和钙调神经磷酸酶在调节疲劳和肌肉修复中的作用,这项工作可能会对运动能力和肌肉老化等领域产生重要影响。
英文摘要
Skeletal muscle, which accounts for a large proportion of our body mass, is not only important for movement and exercise but is also important for other daily functions including energy metabolism. As such maintaining muscle mass is vital to everyday living, and fortunately, our muscle cells have a unique ability to repair itself in the face of damaging stress through a process called muscle regeneration. Calcium is a very powerful signal in skeletal muscle biology/physiology as it activates not only muscle contraction but also a number of proteins that can help to improve exercise performance and our muscle's ability to grow and repair itself. One critical protein involved in calcium signalling in our muscle cells, in fact all of our cells, is calmodulin (CaM), which becomes activated with increased cellular calcium. Once activated, CaM can turn on a number of other proteins (downstream targets), such as calcineurin, which has been shown to enhance fatigue resistance and our muscle's ability to grow and regenerate. Surprisingly, despite the well-known importance of CaM in calcium signalling and skeletal muscle biology/physiology, we know very little with respect to how CaM is regulated in our muscle cells. In contrast, we know much more about how CaM is regulated in our brain and neuronal cells with the discovery and characterization of several CaM-binding proteins that can physically interact with CaM leading to either increased or decreased activation of CaM's downstream targets. One protein in particular is neurogranin (Ng), which, when it binds to CaM, keeps it away from its other downstream targets, like calcineurin, thereby preventing its activation. Recently, we have found that Ng is not only expressed in brain and neuronal cells but also can be found in our muscle cells where it can bind to CaM. However, we still have not figured out how exactly Ng works to regulate CaM in skeletal muscle and whether or not it can influence exercise performance, muscle growth, and repair. Thus, a major long-term objective of this research program is to determine the role of Ng as a CaM regulator in our muscle cells. For this objective, we will use genetically modified mice that do not have Ng in their muscles, and we will perform a number of laboratory techniques to figure out what happens to CaM and calcineurin signalling in muscle, and the impact on the muscle's ability to contract, grow and repair. Overall, this basic research will build a better understanding of the regulation of CaM in skeletal muscle and could lead to the exploration of other CaM binding proteins in skeletal muscle biology/physiology. This work could have important implications that extend into a number of fields such as exercise performance and muscle aging because of CaM and calcineurin's role in regulating fatigue and muscle repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Examining the role of neurogranin in calcineurin activation in rodent skeletal muscle
-
批准号:RGPIN-2019-05833
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.68万
-
财政年份:2021
-
负责人:Fajardo, ValAndrew
-
依托单位:
UltraFocus DXA for longitudinal and non-invasive assessment of rodent body composition
-
批准号:RTI-2021-00799
-
项目类别:Research Tools and Instruments
-
资助金额:$10.93万
-
财政年份:2020
-
负责人:Fajardo, ValAndrew
-
依托单位:
Examining the role of neurogranin in calcineurin activation in rodent skeletal muscle
-
批准号:RGPIN-2019-05833
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.68万
-
财政年份:2020
-
负责人:Fajardo, ValAndrew
-
依托单位:
Examining the role of neurogranin in calcineurin activation in rodent skeletal muscle
-
批准号:RGPIN-2019-05833
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.68万
-
财政年份:2019
-
负责人:Fajardo, ValAndrew
-
依托单位:
Examining the role of neurogranin in calcineurin activation in rodent skeletal muscle
-
批准号:DGECR-2019-00162
-
项目类别:Discovery Launch Supplement
-
资助金额:$0.91万
-
财政年份:2019
-
负责人:Fajardo, ValAndrew
-
依托单位:
Regulation of Skeletal Muscle Mass by Mitochondrial Cardiolipin Content and Composition
-
批准号:487646-2016
-
项目类别:Postdoctoral Fellowships
-
资助金额:$3.28万
-
财政年份:2017
-
负责人:Fajardo, ValAndrew
-
依托单位:
Regulation of Skeletal Muscle Mass by Mitochondrial Cardiolipin Content and Composition
-
批准号:487646-2016
-
项目类别:Postdoctoral Fellowships
-
资助金额:$1.64万
-
财政年份:2016
-
负责人:Fajardo, ValAndrew
-
依托单位:
Regulation of Skeletal Muscle Mass by Mitochondrial Cardiolipin Content and Composition
-
批准号:487646-2016
-
项目类别:Postdoctoral Fellowships
-
资助金额:$1.64万
-
财政年份:2015
-
负责人:Fajardo, ValAndrew
-
依托单位:
Influence of high fat diet on skeltal muscle membranes
-
批准号:381757-2009
-
项目类别:University Undergraduate Student Research Awards
-
资助金额:$0.33万
-
财政年份:2009
-
负责人:Fajardo, ValAndrew
-
依托单位:
Investigating survival analysis
-
批准号:377102-2009
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Master's
-
资助金额:$1.27万
-
财政年份:2009
-
负责人:Fajardo, ValAndrew
-
依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: